Business
Pfizer ends COVID-19 vaccine trial with 95 per cent efficacy – Sydney Morning Herald
Effectiveness of the vaccine was consistent across age and ethnicity demographics, and that there were no major side effects, a sign that the immunisation could…
The better-than-expected data from the two vaccines, both developed with new technology known as messenger RNA (mRNA), have raised hopes for an end to a resurgent pandemic that has killed more than 1.3 million people globally and wreaked havoc upon economies and daily life.
However, while some groups such as healthcare workers will be prioritised in the United States for vaccinations this year, it will be months before large-scale rollouts begin.
Pfizer said on Wednesday there had been 170 cases…
-
Noosa News6 hours agoWoman dead and man rushed to hospital with gunshot wound following crash near Aussie World on Queensland’s Sunshine Coast
-
Noosa News13 hours agoFarmer Fred Perry’s 30-year conservation project creates bird haven after years of ‘bashing and burning’
-
General12 hours agoBoy dies after being trapped between rocks off NSW beach
-
Noosa News13 hours agoDetectives continue to search for answers on Crystal Beale’s death